Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections

Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections

New technologies for the prevention of infectious diseases are emerging to address unmet medical needs, in particular, the use of long-acting monoclonal antibodies (mAb) to prevent Respiratory Syncytial Virus (RSV) lower respiratory tract disease in infants during their first RSV season. The lack of...

Full description

Bibliographic Details
Main Authors: Catherine Weil-Olivier, David Salisbury, José Antonio Navarro-Alonso, Chryssoula Tzialla, Yan Zhang, Susanna Esposito, Fabio Midulla, Tobias Tenenbaum
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
infant immunization
long-acting monoclonal antibody
passive immunization
prophylactic monoclonal antibody
respiratory syncytial virus
Online Access:http://dx.doi.org/10.1080/21645515.2023.2209000

Internet

http://dx.doi.org/10.1080/21645515.2023.2209000

Similar Items